Filtra per Last updated date SelectDopoPrimaFrom - To Date Data di conclusione Questa settimana Questo mese Ultima settimana Ultimo mese Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorPRIMEParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Esito (3827) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 11-13 July 2023 14 Luglio 2023NewsVeterinaryMedicines EMA statement on ongoing review of GLP-1 receptor agonists 11 Luglio 2023NewsHuman Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 3 - 6 July 2023 7 Luglio 2023NewsHumanPharmacovigilanceReferrals Phasing out of extraordinary COVID-19 regulatory flexibilities 6 Luglio 2023NewsHumanCOVID-19 Global regulators confirm good safety profile of COVID-19 vaccines 5 Luglio 2023NewsHumanCOVID-19Medicines Use of real-world evidence in regulatory decision making – EMA publishes review of its studies 23 Giugno 2023NewsHumanData on medicines Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 19-22 June 2023 23 Giugno 2023NewsHumanMedicines ACT EU: creating a better environment for clinical trials through collaboration 22 Giugno 2023NewsHumanClinical trials Report: How EU ensured safety of medicines during COVID-19 22 Giugno 2023NewsHumanPharmacovigilance Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 13-15 June 2023 16 Giugno 2023NewsVeterinaryMaximum residue limitMedicines 1 … 28 29 30 31 32 Page 32 of 383 33 34 35 36 … 383
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 11-13 July 2023 14 Luglio 2023NewsVeterinaryMedicines
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 3 - 6 July 2023 7 Luglio 2023NewsHumanPharmacovigilanceReferrals
Global regulators confirm good safety profile of COVID-19 vaccines 5 Luglio 2023NewsHumanCOVID-19Medicines
Use of real-world evidence in regulatory decision making – EMA publishes review of its studies 23 Giugno 2023NewsHumanData on medicines
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 19-22 June 2023 23 Giugno 2023NewsHumanMedicines
ACT EU: creating a better environment for clinical trials through collaboration 22 Giugno 2023NewsHumanClinical trials
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 13-15 June 2023 16 Giugno 2023NewsVeterinaryMaximum residue limitMedicines